Singular Genomics Systems Inc (NAS:OMIC)
$ 19.6 0.18 (0.93%) Market Cap: 49.66 Mil Enterprise Value: -14.14 Mil PE Ratio: 0 PB Ratio: 0.40 GF Score: 33/100

Q4 2023 Singular Genomics Systems Inc Earnings Call Transcript

Mar 18, 2024 / 08:30PM GMT
Release Date Price: $16.42 (+9.48%)
Operator

Good afternoon, everyone, and welcome to the Singular Genomics Fourth Quarter and Full Year 2023 earnings call. At this time, all participants have been placed on a listen-only mode, and we will open the floor for your questions and comments after the presentation. It is now my pleasure to turn the floor over to your host Philip Taylor. Sir, the floor is yours.

Philip Taylor
Singular Genomics Systems, Inc. - IR

Thank you, operator. Presenting today are Singular Genomics, Founder, Chair and Chief Executive Officer, Drew Spaventa, and the Company's Chief Financial Officer, Dalen Meeter. Earlier today, singular genomics released financial results for the three months ended December 31, 2023. A copy of the press release is available on the company's website before we begin, I would like to inform you that comments and responses to your questions during today's call reflect management's views as of today Monday, March 18, 2024 only and will include forward-looking statements and opinions, statements, including predictions, estimates, plans, expectations and other

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot